NDC 68180-473 – Amlodipine Besylate and Benazepril Hydrochloride

Amlodipine Besylate 10 mg/1; Benazepril Hydrochloride 40 mg/1 · Capsule · Oral

Human Prescription Drug 1 recall

Product NDC68180-473

Product details

Brand name
Amlodipine Besylate and Benazepril Hydrochloride
Generic name
Amlodipine Besylate and Benazepril Hydrochloride
Labeler
Lupin Pharmaceuticals, Inc.
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA078466
Marketed since
October 4, 2018
Listing expires
December 31, 2026
Pharmacologic class
Angiotensin Converting Enzyme Inhibitor; Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker

Active ingredients

Uses, dosage, side effects and warnings for Amlodipine Besylate and Benazepril Hydrochloride →

Package NDC codes (1)

Package NDCDescriptionSince
68180-473-01100 CAPSULE in 1 BOTTLE (68180-473-01)Oct 4, 2018

Recalls mentioning this NDC

Other Amlodipine Besylate and Benazepril Hydrochloride products